Table 2 First-line chemotherapy

From: The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients

Schedule

5FU administration

No. of patients

Bolus FUFOL

Bolus

22

LV5FU2

Bolus+infusional

31

5FU continuous infusion

Infusional

49

FOLFOX2

Infusional

25

FOLFOX4

Bolus+infusional

61

FOLFOX6

Bolus+infusional

78

FOLFIRI

Bolus+infusional

41

Chronomodulated FF

Infusional

110

Chronomodulated FFL

Infusional

186

Various bolus

Bolus

18

Various infusional

Infusional

10

  1. LV5FU2: folinic acid 200 mg sqm day−1 2 h infusion; 5FU 400 mg sqm day−1 bolus; 5FU 600 mg sqm day−1 22 h infusion d1-2q14d
  2. FOLFOX2: oxaliplatin 100 mg sqm−1 d1; folinic acid 300 mg sqm day−1 in 2 h infusion; 5FU 1500–1800 mg sqm day−1 in 22 h infusion d1-2q14d
  3. FOLFOX4: oxaliplatin 85 mg sqm−1 d1; folinic acid 200 mg sqm day−1 2 h infusion; 5FU 400 mg sqm day−1 bolus; 5FU 600 mg sqm day−1 22 h infusion d1-2q14d
  4. FOLFOX6: oxaliplatin 100 mg sqm d1; folinic acid 200 mg sqm−1 2 h infusion; 5FU 400 mg sqm−1 bolus; 5FU 2400–3000 mg sqm−1 46 h infusion
  5. FOLFIRI: irinotecan 180 mg sqm−1 d1; folinic acid 200 mg sqm day−1 2 h infusion; 5FU 400 mg sqm day−1 bolus; 5FU 600 mg sqm day−1 22 h infusion d1-2q14d
  6. Chronomodulated FF: folinic acid 300 mg sqm day−1; 5FU 700–1000 mg sqm day−1 d1-4q14d
  7. Chronomodulated FFL: oxaliplatin 25 mg sqm day−1; folinic acid 300 mg sqm day−1; 5FU 700–1000 mg sqm day−1 d1-4q14d.